Skip to main content
. 2020 Jul 1;10(8):1542–1549. doi: 10.1002/2211-5463.12909

Fig. 1.

Fig. 1

Survival and disease‐/progression‐free of the patients with or without TTK alteration. (A) Survival of the patients with or without TTK alteration. P‐value = 0.0139. (B) Disease‐/progression‐free survival of patients with or without TTK alteration. P‐value = 0.00387. All patient data were collected from TCGA database. (C). TTK expression profile in gastric cancer samples and paired normal tissues. Data represent means ± SD of triplicate assays and were analyzed by unpaired t‐test. ** P < 0.01.